The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessing the added value of breast tumor markers in breast cancer genetic risk prediction model BRCAPRO.
B. Arun
No relevant relationships to disclose
S. Biswas
No relevant relationships to disclose
N. Tankhiwale
No relevant relationships to disclose
A. L. Blackford
No relevant relationships to disclose
A. M. Gutierrez-Barrera
No relevant relationships to disclose
J. K. Litton
No relevant relationships to disclose
G. N. Hortobagyi
No relevant relationships to disclose
C. I. Amos
No relevant relationships to disclose
G. Parmigiani
No relevant relationships to disclose